Deletion at 6q24.2–26 predicts longer survival of high‐grade serous epithelial ovarian cancer patients

Standard treatments for advanced high‐grade serous ovarian carcinomas (HGSOCs) show significant side‐effects and provide only short‐term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin‐embedd...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Kamieniak, Marta M., Rico, Daniel, Milne, Roger L., Muñoz-Repeto, Ivan, Ibáñez, Kristina, Grillo, Miguel A., Domingo, Samuel, Borrego, Salud, Cazorla, Alicia, García-Bueno, José M., Hernando, Susana, García-Donas, Jesús, Hernández-Agudo, Elena, y Cajal, Teresa Ramón, Robles-Díaz, Luis, Márquez-Rodas, Ivan, Cusidó, Maite, Sáez, Raquel, Lacambra-Calvet, Carmen, Osorio, Ana, Urioste, Miguel, Cigudosa, Juan C., Paz-Ares, Luis, Palacios, José, Benítez, Javier, García, María J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2014
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528660/
https://ncbi.nlm.nih.gov/pubmed/25454820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.09.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars